QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, August 11, 2004, 24(32):7194-7198; doi:10.1523/JNEUROSCI.1933-04.2004

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (28) Citing Articles via Google Scholar Google Scholar Articles by Anderson, E. R. Articles by Xiong, H. Search for Related Content PubMed PubMed Citation Articles by Anderson, E. R. Articles by Xiong, H.

 Previous Article  |  Next Article 

BRIEF COMMUNICATION
Memantine Protects Hippocampal Neuronal Function in Murine Human Immunodeficiency Virus Type 1 Encephalitis

Eric R. Anderson,^1,2 Howard E. Gendelman,^1,2,3 and Huangui Xiong^1,2

¹Center for Neurovirology and Neurodegenerative Disorders and Departments of ²Pathology and Microbiology and ³Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska 68198-5880

Memantine, a low-to-moderate-affinity NMDA receptor antagonist, can be used to treat cognitive impairment associated with Alzheimer's disease. However, its potential neuroprotective effects for human immunodeficiency virus type 1-associated (HIV-1-associated) dementia are less well appreciated. To this end we studied hippocampal synaptic function in a severe combined immunodeficient (SCID) mouse model of HIV-1 encephalitis (HIVE). Human monocyte-derived macrophages (MDMs) infected with HIV-1_ADA were injected stereotactically into the caudate and putamen of SCID mice, generating HIVE. These brain subregions are among those most affected in humans. Impaired synaptic transmission and long-term potentiation (LTP) were detected in the CA1 region of hippocampal brain slices of HIVE mice. Memantine-treated HIVE mice showed significant improvements in synaptic function during frequency facilitation tests and LTP induced by high-frequency stimulation when compared with untreated animals. Immunocytochemical measures of neuronal antigens mirrored the neuronal physiological tests. These results demonstrate that memantine attenuates hippocampal synaptic impairment in murine HIVE and provide a rationale for its use in infected humans who experience cognitive decline.

Key words: memantine; HIV-1 encephalitis; monocyte-derived macrophages; neuroprotection; hippocampal slices; severe combined immunodeficient mice

---

Received May 18, 2004; revised July 2, 2004; accepted July 6, 2004.

This article has been cited by other articles:

				H. J. Kim, K. A. Martemyanov, and S. A. Thayer Human Immunodeficiency Virus Protein Tat Induces Synapse Loss via a Reversible Process That Is Distinct from Cell Death J. Neurosci., November 26, 2008; 28(48): 12604 - 12613. [Abstract] [Full Text] [PDF]

				M. J. Repetto and J. M. Petitto Psychopharmacology in HIV-Infected Patients Psychosom Med, June 1, 2008; 70(5): 585 - 592. [Abstract] [Full Text] [PDF]

				J.M.B. Castelo, S. J. Sherman, M. G. Courtney, R. J. Melrose, and C. E. Stern Altered hippocampal-prefrontal activation in HIV patients during episodic memory encoding Neurology, June 13, 2006; 66(11): 1688 - 1695. [Abstract] [Full Text] [PDF]

				H. Dou, B. Ellison, J. Bradley, A. Kasiyanov, L. Y. Poluektova, H. Xiong, S. Maggirwar, S. Dewhurst, H. A. Gelbard, and H. E. Gendelman Neuroprotective Mechanisms of Lithium in Murine Human Immunodeficiency Virus-1 Encephalitis J. Neurosci., September 14, 2005; 25(37): 8375 - 8385. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help